Inventor · disambiguated record
You-Ping Chan
Also filed as: CHAN YOU P N C · CHAN YOU-PING
43 granted patents·21 pending applications·550 citations·filing 1990–2024
98Inventor score
Top patents by PatentIndex Score
64 records- 0193US7683024B2Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applicationsFLAMEL TECH SA·Filed 2003·Granted Mar 23, 2010·55 cites·24 claims
- 0292US6506538B1Naphthopyrans annelated in C5-C6, their preparation and compositions and (co)polymer matrices containing themCORNING SA·Filed 1999·Granted Jan 14, 2003·42 cites·15 claims
- 0392US6018059A(Benzofuran) naphthopyrans, the compositions and (co)polymer matrices containing themCORNING INC·Filed 1997·Granted Jan 25, 2000·50 cites·21 claims
- 0491US10052289B2Composition comprising an active agent with low aqueous solubilityMEYRUEIX REMI·Filed 2009·Granted Aug 21, 2018·36 cites·38 claims
- 0588US6096246APhotochromic naphthopyrans, compositions and articles containing themCORNING INC·Filed 1997·Granted Aug 1, 2000·43 cites·21 claims
- 0688US5811507APolyesterimides for use in linear and/or non-linear optics, and one method for preparing sameFLAMEL TECH SA·Filed 1994·Granted Sep 22, 1998·45 cites·28 claims
- 0787US6506322B1Naphthopyrans annelated in C5-C6 with an indene- or dihydronaphthalene-type carbocycle, and compositions and (co)polymer matrices containing themCORNING INC·Filed 2000·Granted Jan 14, 2003·21 cites·26 claims
- 0884US11065305B2Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial actionADOCIA·Filed 2020·Granted Jul 20, 2021·1 cites·19 claims
- 0984US7678882B2Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereofFLAMEL TECH SA·Filed 2006·Granted Mar 16, 2010·3 cites·25 claims
- 1084US6558583B2Naphthopyrans annelated in C5-C6 with a dihydrobenzo-cycloheptatriene-type carbocycle and compositions and matrices containing themCORNING INC·Filed 2001·Granted May 6, 2003·19 cites·20 claims
- 1183US6398987B1Naphthopyrans having a perfluoroalkyl substituent in position 5, preparation and compositions and matrices containing themCORNING SA·Filed 2000·Granted Jun 4, 2002·14 cites·27 claims
- 1283US6210608B1Naphthopyrans and phenanthropyrans annelated in C5-C6 with a bicycle group and compositions and (co) polymer matrices containing themCORNING SA·Filed 2000·Granted Apr 3, 2001·12 cites·33 claims
- 1381US10610572B2Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial actionADOCIA·Filed 2018·Granted Apr 7, 2020·2 cites·20 claims
- 1481US7919572B2Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applicationsFLAMEL TECH SA·Filed 2004·Granted Apr 5, 2011·14 cites·21 claims
- 1581US6719925B1Naphthopyrans with a heterocycle in the 5, 6-position, preparation, and (co)polymer compositions and matrices containing themCORNING SAS·Filed 2000·Granted Apr 13, 2004·17 cites·37 claims
- 1679US8236353B2Self-precipitating pharmaceutical formulations for the modified release of an active principleCHECOT FREDERIC·Filed 2008·Granted Aug 7, 2012·4 cites·14 claims
- 1778US11191812B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Granted Dec 7, 2021·1 cites·17 claims
- 1878US2025099551A1Thermostable formulation of a21g human insulinADOCIA·Filed 2024·Application pending·0 cites
- 1977US7659365B2Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applicationsFLAMEL TECH SA·Filed 2004·Granted Feb 9, 2010·6 cites·18 claims
- 2076US6030555APhotochromic spiroxazines, compositions and articles containing themCORNING INC·Filed 1996·Granted Feb 29, 2000·20 cites·44 claims
- 2176US6001958ACrosslinkable polymer, particularly for optical and non-linear optical use, materials or devices using same, and method for preparing said polymerFLAMEL TECH SA·Filed 1994·Granted Dec 14, 1999·22 cites·20 claims
- 2275US11633460B2Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Granted Apr 25, 2023·2 cites·15 claims
- 2375US6004486APhotochromic spiroxazines with asymmetric monocyclic substituent, compositions and articles containing themCORNING INC·Filed 1996·Granted Dec 21, 1999·38 cites·28 claims
- 2475US2025090638A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2024·Application pending·0 cites
- 2569US5112999AIridium complexes, process for their preparation and their useCIBA GEIGY CORP·Filed 1990·Granted May 12, 1992·13 cites·18 claims
- 2669US2019216931A1Injectable ph 7 solution comprising at least one basal insulin having a pi from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 2768US7332260B2Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing themCORNING INC·Filed 2002·Granted Feb 19, 2008·5 cites·13 claims
- 2868US6426023B1Benzopyrans annelated in C7-C8 with an aromatic heterocycle and compositions and (CO)polymer matrices containing themCORNING SA·Filed 2000·Granted Jul 30, 2002·12 cites·18 claims
- 2967US7250120B2Benzo-, naphtho- and phenanthrochromene substituted by carbamated or ureated phenyls, preparation thereof and compositions and articles containing themCORNING INC·Filed 2004·Granted Jul 31, 2007·3 cites·19 claims
- 3065US5888432A2-Adamantyl benzopyrans the compositions and (co)polymer matrices containing themCORNING INC·Filed 1997·Granted Mar 30, 1999·8 cites·10 claims
- 3164US12186373B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2021·Granted Jan 7, 2025·0 cites·12 claims
- 3264US2008102128A1Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising themFLAMEL TECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 3364US2021315977A1Thermostable formulation of a21g human insulinADOCIA·Filed 2019·Application pending·0 cites
- 3462US8716217B2Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereofCHAN YOU-PING·Filed 2008·Granted May 6, 2014·1 cites·18 claims
- 3562US2022409523A1Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 3661US2014105993A1Modified-release microparticles based on amphiphilic copolymer and on active principle(s) and pharmaceutical formulations comprising themFLAMEL TECHNOLOGIES S A·Filed 2013·Application pending·0 cites
- 3761US2010048735A1Polyaminoacids functionalized wtih alpha-tocopherol, and uses thereof, especially therapeutic usesFLAMEL TECHNOLOGIES S A·Filed 2009·Application pending·0 cites
- 3860US6444860B2Naphthopyrans and phenanthropyrans annelated in C5-C6 with a bicyclic group, and compositions and (co) polymer matrices containing themCORNING SA·Filed 2000·Granted Sep 3, 2002·1 cites·12 claims
- 3960US2021386830A1Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2021·Application pending·0 cites
- 4059US11883496B2Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2020·Granted Jan 30, 2024·0 cites·24 claims
- 4157US2023210957A1Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial actionADOCIA·Filed 2021·Application pending·0 cites
- 4256US11173109B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acidADOCIA·Filed 2018·Granted Nov 16, 2021·0 cites·18 claims
- 4356US8481019B2Modified-release particles of polyelectrolytes and pharmaceutical formulations thereofBONNET-GONNET CECILE·Filed 2008·Granted Jul 9, 2013·0 cites·19 claims
- 4456US2023201312A1Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid-acting insulin analog and a glucagon suppressor with prandial actionADOCIA·Filed 2021·Application pending·0 cites
- 4553US6207084B1Naphthopyrans annelated in C6-C7, their preparation and compositions and (CO)polymer matrices containing themCORNING SA·Filed 1999·Granted Mar 27, 2001·5 cites·26 claims
- 4652US2019388515A1Injectable solution at ph 7 comprising at least one basal insulin the pi of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2019·Application pending·0 cites
- 4751US2010098656A1Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applicationsFLAMEL TECH SA·Filed 2005·Application pending·0 cites
- 4850US2011044930A1Copolyhydroxyalkylglutamines functionalised with hydrophobic groups, and uses thereof, especially in therapeuticsSOULA REMI·Filed 2006·Application pending·0 cites
- 4949US11129877B2Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acidADOCIA·Filed 2018·Granted Sep 28, 2021·0 cites·13 claims
- 5049US10987426B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2018·Granted Apr 27, 2021·0 cites·23 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →